Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
about
Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationEvaluation of 1p36 markers and clinical outcome in a skull base chordoma study.The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.Differential proteomic profiling of chordomas and analysis of prognostic factors.Fine needle aspiration cytology of primary or recurrent chordomas.Recurrent chromosomal copy number alterations in sporadic chordomas.In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.Frequent activation of EGFR in advanced chordomas.'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12Chordoma: an update on the pathophysiology and molecular mechanismsPrognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.On a Rare Cutaneous Metastasis from a Sacrococcygeal Chordoma.Expression and Therapeutic Potential of SOX9 in Chordoma.iASPP overexpression is associated with clinical outcome in spinal chordoma and influences cellular proliferation, invasion, and sensitivity to cisplatin in vitro.
P2860
Q24651310-B75FA9BE-F710-46C7-9F60-175A011F20E1Q33273004-72A049F4-FF0E-45A7-B820-04D60E85A2C8Q33273878-BDD66FE5-8F41-441F-84DF-2B48B7CC007AQ33273896-5997EA91-2476-4153-B4C4-D67B431F7794Q33273925-D8ACD834-0DFD-431A-90A3-D4BAD580BC02Q33274149-42D4D3A9-448E-41E3-BD13-91821A9F1CEBQ33274229-5C33E4ED-93EC-47C5-AE22-0B247DAD9BA8Q33274473-57FD5CD7-7548-4A3B-8580-CC9D22EF95DFQ33274565-9E53BC35-D145-49FE-A126-5BCE282CF752Q33275053-700783B3-E4DB-4302-AD19-434071932611Q33275783-E100DECD-14E9-4399-8B7F-EFAD9C7853D0Q33275854-E4D04932-777B-4629-9BED-23CDF34774DBQ33276454-58243D1F-A4F9-4F9D-99C9-A3A8D300E2AAQ33276544-052F9143-D19F-45CF-8A9F-18848D78930AQ42117189-9E819BD4-AA34-4FE5-9618-8671883C1287
P2860
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@ast
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@en
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@nl
type
label
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@ast
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@en
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@nl
prefLabel
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@ast
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@en
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@nl
P2093
P50
P356
P1433
P1476
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
@en
P2093
Albert Roessner
Amir Samii
Angela Kellner
Christian Herold
Doerthe Kuester
Regine Schneider-Stock
Takahiko Naka
P304
P356
10.1002/CNCR.21296
P407
P577
2005-09-01T00:00:00Z